From: Older people’s attitudes towards deprescribing cardiometabolic medication
Number of participants (n) | Mean | SD | P value | Effect size (Cohen’s D) | |
Appropriateness of the medicationd | |||||
Insulina | 32 | 3.81 | 0.84 | 0.026* | 0.51 |
Sulfonylureae | 50 | 3.43 | 0.68 | ||
Insulina | 32 | 3.81 | 0.84 | 0.002** | 0.59 |
Statins | 209 | 3.38 | 0.71 | ||
Sulfonylureasa | 64 | 3.56 | 0.75 | 0.20 | 0.21 |
Antihypertensive | 182 | 3.69 | 0.61 | ||
Statinb | 170 | 3.38 | 0.69 | < 0.001** | 0.47 |
Antihypertensive | 170 | 3.68 | 0.63 | ||
(n) | Median | IQR | P value | Effect size | |
Insulinc | 32 | 3.8 | 2.2–3.4 | 0.53 | 0.19 |
Antihypertensive | 182 | 3.8 | 2.4–3.0 | ||
Sulfonylureac | 64 | 3.6 | 2.0–3.0 | 0.090 | 0.24 |
Statin | 209 | 3.4 | 1.8–3.0 | ||
Concerns about stopping medication | |||||
(n) | Mean | SD | P value | Effect size | |
Insulina | 31 | 2.61 | 0.83 | 0.88 | 0.040 |
Sulfonylurea | 46 | 2.59 | 0.51 | ||
Insulina | 32 | 2.63 | 0.82 | 0.86 | 0.034 |
Antihypertensive | 183 | 2.65 | 0.64 | ||
Insulin a | 32 | 2.63 | 0.82 | 0.86 | 0.041 |
Statin | 204 | 2.60 | 0.60 | ||
Sulfonylurea a | 58 | 2.59 | 0.60 | 0.52 | 0.097 |
Antihypertensive | 183 | 2.65 | 0.64 | ||
Sulfonylureaa | 58 | 2.59 | 0.62 | 0.89 | 0.021 |
Statin | 204 | 2.60 | 0.60 | ||
Statin b | 169 | 2.57 | 0.58 | 0.19 | 0.079 |
Antihypertensive | 169 | 2.63 | 0.65 |